恶唑啉|Oxazolines-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

恶唑啉是一种含氧原子和氮原子的五元杂环化合物。它可能最早合成于1884年，但直到5年后，西格蒙·加布里埃尔才正确地指定了这种结构。它与Hantzsch–Widman命名法一致，是一族杂环化合物的一部分，在饱和度方面它存在于噁唑和噁唑烷之间。

按化学元素: B^x; C^x; N^x; O^x; F^x; Si^x; P^x; S^x; Cl^x; Br^x; I^x

官能团： 酯 (2) 芳基 (7) 酰胺 (1)

母核：

按纯度： 99+% 99% 98+% 98% 97+% 97% 96+% 96% 95+% 95% 93% 90+% 90%

按分子量： 0-100 100-200 200-300 300-400 400-500 500-600

按化学元素： CINO CNOSSi CNOP CClFNO CINOS CBrNO CFINO CNOSi CClNOS COS CNO CNOS CNOSe CFNOS CBrKNO CClFNOS CBrNOS CBrClNO CClNO CBrFNO CBrNOSe CFNO CFNOSe CBNO 更多

(R)-Ethyl 6-(4-phenyl-4,5-dihydrooxazol-2-yl)nicotinate (R)-6-(4-苯基-4,5-二氢恶唑-2-基)烟酸乙酯: BJS12792761085431-16-898%; ￥1829.00100mg

(S,S)-4,4-Dimethyl-4,5,4',5'-tetrahydro [2.2]bioxazolyl (4S,4S')-4,4-二甲基-4,5,4',5'-四氢[2.2]双噁唑基: BJS4808985336884-31-298% 99%ee; ￥494.00250mg

(S)-N-(2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)-6-methylphenyl)methanesulfonamide (S)-N-(2-(4-异丙基-4,5-二氢恶唑-2-基)-6-甲基苯基)甲磺酰胺: BJS6984460480444-15-395%; ￥2090.00100mg

(3aR,8aS)-2-(Pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole (3aR,8aS)-3a,8a-二氢-2-(2-吡啶基)-8H-茚并[1,2-d]噁唑: BJS9573686330443-74-897% 99%ee; ￥185.0050mg

(R)-4-Isopropyl-2-(quinolin-2-yl)-4,5-dihydrooxazole (R)-4-异丙基-2-(喹啉-2-基)-4,5-二氢噁唑: BJS2178951933992-49-597% 99%ee; ￥214.00250mg

(R)-4-Isopropyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole (R)-4-异丙基-2-(5-(三氟甲基)吡啶-2-基)-4,5-二氢噁唑: BJS79333922010973-00-798%; ￥336.00100mg

(4R,4'R)-2,2'-Methylenebis[4,5-dihydro-4-(1-methylethyl)oxazole] (4R,4'R)-2,2'-亚甲基双[4,5-二氢-4-(1-甲基乙基)噁唑]: BJS8410140164976-63-095%; ￥416.00250mg

(S)-2-(4-Methoxy-6-methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole (S)-2-(4-甲氧基-6-甲基吡啶-2-基)-4-苯基-4,5-二氢噁唑: BJS61820342757082-39-498%; ￥2075.00100mg

(3aS,8aR)-2-(6-Methylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole (3aS,8aR)-2-(6-甲基吡啶-2-基)-3a,8a-二氢-8H-茚并[1,2-d]恶唑: BJS17183351532531-18-297% 99%ee; ￥2703.00250mg

4-(tert-Butyl)-2-(quinolin-2-yl)-4,5-dihydrooxazole 4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑: BJS98602842246335-51-198%; ￥422.00100mg

(S)-4-((R)-sec-Butyl)-2-(pyridin-2-yl)-4,5-dihydrooxazole (S)-4-((R)-仲丁基)-2-(吡啶-2-基)-4,5-二氢恶唑: BJS62518872634687-84-497%; ￥1033.00250mg

(4S,4'S)-4,4'-Diisobutyl-4,4',5,5'-tetrahydro-2,2'-bioxazole (4S,4'S)-4,4'-二异丁基-4,4',5,5'-四氢-2,2'-联恶唑: BJS2776536138429-17-198%; ￥12054.001g

(R)-4-Isobutyl-2-(pyridin-2-yl)-4,5-dihydrooxazole (R)-4-异丁基-2-(吡啶-2-基)-4,5-二氢恶唑: BJS88589952757082-82-798%; ￥645.00100mg

(R)-4-(tert-Butyl)-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole (R)-4-(叔丁基)-2-(6-甲基吡啶-2-基)-4,5-二氢恶唑: BJS40033712491654-89-697%; ￥2161.00100mg

(R)-4-Benzyl-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole (R)-4-苄基-2-(6-甲基吡啶-2-基)-4,5-二氢恶唑: BJS26552692757082-98-597% 99%ee; ￥1964.00100mg

(S)-2-(6-Methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole (S)-2-(6-甲基吡啶-2-基)-4-苯基-4,5-二氢恶唑: BJS54230801308311-03-697%; ￥699.00100mg

(S)-4-Benzyl-2-(5-chloropyridin-2-yl)-4,5-dihydrooxazole (S)-4-苄基-2-(5-氯吡啶-2-基)-4,5-二氢恶唑: BJS74635802757083-21-797%; ￥2001.00250mg

(3aS,8aR)-2-(5-Chloropyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole (3aS,8aR)-2-(5-氯吡啶-2-基)-3a,8a-二氢-8H-茚并[1,2-d]恶唑: BJS35091832757083-22-897% 99%ee; ￥6004.001g

(R)-2-(6-Cyclopropylpyridin-2-yl)-4-ethyl-4,5-dihydrooxazole (R)-2-(6-环丙基吡啶-2-基)-4-乙基-4,5-二氢恶唑: BJS92060502828438-70-497%; ￥935.00100mg

(S)-4-((S)-sec-Butyl)-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole (S)-4-((S)-仲丁基)-2-(5-(三氟甲基)吡啶-2-基)-4,5-二氢恶唑: BJS12665422828439-59-295%; ￥3669.00250mg

1 2 3 4 5 6 7 8 9 ... 15